Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 12 | 27 | 26 | 26 | 25 |
| Accounts receivable | 27 | -114 | -30 | 84 | 67 |
| Other Working Capital | 777 | 119 | -631 | -622 | 671 |
| Other Operating Activity | -5,195 | -7,550 | -4,590 | -6,412 | -5,314 |
| Operating Cash Flow | $-4,379 | $-7,518 | $-5,225 | $-6,925 | $-4,551 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -48 | -3 | -3 | -6 |
| Investing Cash Flow | $-3 | $-48 | $-3 | $-3 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -14 | -14 | -14 | -14 | -14 |
| Common Stock Issued | 0 | 14,850 | N/A | N/A | N/A |
| Other Financing Activity | 2,491 | -1,236 | 15,561 | 0 | 34 |
| Financing Cash Flow | $2,477 | $13,600 | $15,547 | $-14 | $20 |
| Exchange Rate Effect | 313 | 222 | -524 | 369 | -561 |
| Beginning Cash Position | 27,673 | 21,417 | 11,622 | 18,195 | 23,293 |
| End Cash Position | 26,081 | 27,673 | 21,417 | 11,622 | 18,195 |
| Net Cash Flow | $-1,905 | $6,035 | $10,319 | $-6,942 | $-4,537 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,379 | -7,518 | -5,225 | -6,925 | -4,551 |
| Capital Expenditure | -3 | -48 | -3 | -3 | -6 |
| Free Cash Flow | -4,382 | -7,565 | -5,228 | -6,928 | -4,557 |